Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BJDX Bluejay Diagnostics Inc

Not Yet Opened 11-06 16:00:00 EST

2.35

+0.16

+7.31%

盘后2.23

-0.12-5.11%

19:30 EST

High2.41	Low2.22	Vol16.93K
Open2.22	D1 Closing2.19	Amplitude8.68%
Mkt Cap2.63M	Tradable Cap2.57M	Total Shares1.12M
T/O38.63K	T/O Rate1.55%	Tradable Shares1.09M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BJDX","market":"US","secType":"STK","nameCN":"Bluejay Diagnostics Inc","latestPrice":2.35,"timestamp":1793998800000,"preClose":2.19,"halted":0,"volume":16932,"hourTrading":{"tag":"盘后","latestPrice":2.23,"preClose":2.35,"latestTime":"19:30 EST","volume":1527,"amount":3409.05,"timestamp":1794011403354,"change":-0.12,"changeRate":-0.051064,"amplitude":0.051064},"delay":0,"changeRate":0.07305936073059367,"floatShares":1094295,"shares":1117025,"eps":-26.59066,"marketStatus":"Not Yet Opened","change":0.16,"latestTime":"11-06 16:00:00 EST","open":2.22,"high":2.41,"low":2.22,"amount":38628.0823392,"amplitude":0.086758,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-26.59066,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":0,"adr":0,"listingDate":1636520400000,"exchange":"NASDAQ","adjPreClose":2.19,"preHourTrading":{"tag":"盘前","latestPrice":2.2,"preClose":2.19,"latestTime":"09:02 EST","volume":1252,"amount":2649.390378,"timestamp":1793973757508,"change":0.01,"changeRate":0.004566,"amplitude":0.164384},"postHourTrading":{"tag":"盘后","latestPrice":2.23,"preClose":2.35,"latestTime":"19:30 EST","volume":1527,"amount":3409.05,"timestamp":1794011403354,"change":-0.12,"changeRate":-0.051064,"amplitude":0.051064},"volumeRatio":0.10769211192316022},"requestUrl":"/m/hq/s/BJDX/wiki","defaultTab":"wiki","newsList":[{"id":"2680030780","title":"Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split Effective November 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2680030780","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680030780?lang=en_us&edition=fundamental","pubTime":"2026-11-04 19:32","pubTimestamp":1793791928,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split Effective November 3Bluejay Diagnostics will implement a 1-for-4 reverse stock split effective at 12:01 a.m. Eastern Time on November 3, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL5yNfG9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680768797","title":"Bluejay Diagnostics Inc trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2680768797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680768797?lang=en_us&edition=fundamental","pubTime":"2026-11-03 08:50","pubTimestamp":1793667010,"startTime":"0","endTime":"0","summary":"19:50 EST Bluejay Diagnostics (BJDX) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679248962","title":"Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split Effective November 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2679248962","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679248962?lang=en_us&edition=fundamental","pubTime":"2026-10-30 22:30","pubTimestamp":1793370649,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split Effective November 3Bluejay Diagnostics will implement a 1-for-4 reverse stock split effective at 12:01 a.m. Eastern Time on November 3, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261030:nNDL71HJKl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675335722","title":"Bluejay Diagnostics Expands Symphony IL-6 Manufacturing Capabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2675335722","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675335722?lang=en_us&edition=fundamental","pubTime":"2026-10-13 21:29","pubTimestamp":1791898168,"startTime":"0","endTime":"0","summary":"An announcement from Bluejay Diagnostics ( ($BJDX) ) is now available. On October 13, 2026, Bluejay Diagnostics announced it had completed the esta...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-expands-symphony-il-6-manufacturing-capabilities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-expands-symphony-il-6-manufacturing-capabilities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675353481","title":"Bluejay Diagnostics Completes Symphony Cartridge Manufacturing Site, Bolstering Supply-Chain Resilience","url":"https://stock-news.laohu8.com/highlight/detail?id=2675353481","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675353481?lang=en_us&edition=fundamental","pubTime":"2026-10-13 18:31","pubTimestamp":1791887519,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics completes Symphony cartridge manufacturing site, bolstering supply-chain resilienceBluejay Diagnostics completed establishment of a Symphony cartridge manufacturing site, meeting a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261013:nNDL5gRP21:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673051023","title":"Bluejay Unveils SYMON-II Baseline Data for Symphony Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2673051023","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673051023?lang=en_us&edition=fundamental","pubTime":"2026-10-06 21:34","pubTimestamp":1791293678,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics ( ($BJDX) ) just unveiled an announcement. On October 6, 2026, Bluejay Diagnostics reported baseline clinical characteristics f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-unveils-symon-ii-baseline-data-for-symphony-test?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-unveils-symon-ii-baseline-data-for-symphony-test?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673582070","title":"Bluejay Diagnostics Details SYMON-II Dataset for IL-6 Sepsis Mortality Risk Evaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=2673582070","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673582070?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:30","pubTimestamp":1791282618,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics details SYMON-II dataset for IL-6 sepsis mortality risk evaluationBluejay Diagnostics released baseline data from its SYMON-II clinical validation study evaluating IL-6 for 28-day ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDLbLMYxC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370136","title":"Bluejay Diagnostics expands federal access via Lovell partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370136?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:19","pubTimestamp":1788902399,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics ( ($BJDX) ) has shared an update. On September 1, 2026, Bluejay Diagnostics entered a distribution, co-marketing and strategic ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-expands-federal-access-via-lovell-partnership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-expands-federal-access-via-lovell-partnership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665324104","title":"Bluejay Diagnostics and Lovell Government partner to access federal healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2665324104","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665324104?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:35","pubTimestamp":1788863707,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics (BJDX) and Lovell Government Services, a Service-Disabled Veteran-Owned Company specializing in federal healthcare distribution...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-and-lovell-government-partner-to-access-federal-healthcare-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-and-lovell-government-partner-to-access-federal-healthcare-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","NOBL","BK4588","CGCV","BK4585","TCAF","IXJ","BK4550","BK4082","VHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665324533","title":"Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2665324533","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665324533?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:30","pubTimestamp":1788863400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA8M5H2K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659544111","title":"Bluejay Advances Symphony Platform, Strengthens Cash Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2659544111","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659544111?lang=en_us&edition=fundamental","pubTime":"2026-08-13 20:17","pubTimestamp":1786623474,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics ( ($BJDX) ) has provided an announcement. On August 13, 2026, Bluejay Diagnostics reported second-quarter 2026 results, highlig...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-advances-symphony-platform-strengthens-cash-position?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-advances-symphony-platform-strengthens-cash-position?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659685153","title":"Bluejay Diagnostics Q2 EPS $(1.12) Up From $(5.64) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2659685153","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659685153?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:17","pubTimestamp":1786616272,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.12) per share. This is a 80.14 percent increase over losses of $(5.64) per share from the same period last year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61167382/bluejay-diagnostics-q2-eps-1-12-5-64-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659158032","title":"Bluejay Diagnostics Says SYMON-II Pivotal Study Completes Enrollment of 750 Patients for Symphony IL-6 Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2659158032","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659158032?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:04","pubTimestamp":1786615496,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics says SYMON-II pivotal study completes enrollment of 750 patients for Symphony IL-6 testBluejay Diagnostics reported Q2 2026 progress on its SYMON-II pivotal study for the investiga","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDLhvCLd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659117158","title":"Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony™ Il-6 Toward Regulatory Submission and Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2659117158","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659117158?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:00","pubTimestamp":1786615201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nTUAB7ZFPM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659158166","title":"Press Release: Bluejay Diagnostics Reports Q2 2026 Results; Strengthened Balance Sheet Supports Advancement of Symphony(TM) IL-6 Toward Regulatory Submission and Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2659158166","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659158166?lang=en_us&edition=fundamental","pubTime":"2026-08-13 18:00","pubTimestamp":1786615200,"startTime":"0","endTime":"0","summary":"-- SYMON-II pivotal clinical study completes targeted enrollment of 750. -- Company advances toward planned 510 submission and commercialization. with US manufacturing contract signed to mitigate supply-chain risk. -- Company ends second quarter with approximately $9.6 million in cash","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4555","03160","BK4585","TM","BK4604","BK4588","BK4082","BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900393","title":"Bluejay Net Loss Widens to $2.32 Million in Q2 FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900393","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900393?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:12","pubTimestamp":1786565570,"startTime":"0","endTime":"0","summary":"Bluejay net loss widens to $2.32 million in Q2 FY26Bluejay Diagnostics posted a net loss of USD 2.32 million for the quarter ended June 30, 2026, widening from USD 1.96 million.Operating loss widened ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL9lps6c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657549520","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657549520","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657549520?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:26","pubTimestamp":1785929213,"startTime":"0","endTime":"0","summary":"C3is  stock was up more than 65% in Wednesday's premarket activity after closing Tuesday with a 21% decreaseBluejay Diagnostics  shares were 38% higher pre-bell, extending an over 5% rise in the previous session.Julong  stock was up 37% after a 12% loss at the prior close.Gran Tierra Energy  shares were 48% higher after the company agreed to sell its oil business in Colombia and Ecuador to French oil and natural gas exploration and production company Maurel & Prom for an enterprise value of $1.33 billion.Jin Medical International  stock was up more than 28% following the release of its fiscal H1 results.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GTE","PXJ","BK7095","DRLL","FTXN","BK4082","JLHL","WTIU","BJDX","CISS","DBC","BK4213","DIG","XOP","USE","VDE","BK4588","DRIP","BK4585","PXE","BK4129","DBE","BK4570","BK4021","DUG","GUSH","GTE.AU","XES","IEO","ZJYL","ERX","IXC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653799188","title":"Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2653799188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653799188?lang=en_us&edition=fundamental","pubTime":"2026-07-23 05:48","pubTimestamp":1784756919,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Bluejay Diagnostics ( ($BJDX) ). On July 21, 2026, Bluejay Diagnostics announced it had completed patient enrol...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-completes-enrollment-in-symon-ii-sepsis-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bluejay-diagnostics-completes-enrollment-in-symon-ii-sepsis-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653762673","title":"Bluejay Diagnostics Initial Beneficial Ownership Statement Names Bank of America as 10% Owner","url":"https://stock-news.laohu8.com/highlight/detail?id=2653762673","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653762673?lang=en_us&edition=fundamental","pubTime":"2026-07-23 01:30","pubTimestamp":1784741418,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics initial beneficial ownership statement names Bank of America as 10% ownerBluejay Diagnostics Form 3 disclosed Bank of America entities as 10% owners, reporting beneficial ownership","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nNDL1qTtnv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYG","FNCL","LU1883839398.USD","BK4082","LU1668664300.SGD","LU0130102774.USD","LU0130103400.USD","IE00BZ1G4Q59.USD","LU1880398554.USD","BJDX","BAC","LU1718418525.SGD","IE0001KFT4U8.USD","LU0149725797.USD","IE00B1BXHZ80.USD","LU0320765646.SGD","XLF","LU1280957306.USD","LU0053666078.USD","LU0128525689.USD","IE0034235188.USD","LU0234570918.USD","LU0256863902.USD","LU2129689605.HKD","LU0314106906.USD","VFH","BK4534","LU0070302665.USD","FTXO","LU1201861249.SGD","IE00BFXG1179.USD","LU2129689431.USD","LU2596442595.SGD","LU0203345920.USD","LU0683600562.USD","LU1791807156.HKD","LU2129689514.USD","LU0980610538.SGD","LU0130518102.USD","TFNS","IYF","KBWB","UYG","LU1880398471.USD","BK4585","LU1894683264.USD","BK4588","LU2265009873.SGD","LU0203347892.USD","LU1267930227.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653927953","title":"Bluejay Diagnostics completes enrollment in SYMON-II study","url":"https://stock-news.laohu8.com/highlight/detail?id=2653927953","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653927953?lang=en_us&edition=fundamental","pubTime":"2026-07-21 18:35","pubTimestamp":1784630118,"startTime":"0","endTime":"0","summary":"Bluejay Diagnostics (BJDX) announced the successful completion of patient enrollment in its SYMON-II multicenter clinical validation study. The stu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-completes-enrollment-in-symon-ii-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bluejay-diagnostics-completes-enrollment-in-symon-ii-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BJDX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://bluejaydx.com","stockEarnings":[{"period":"1week","weight":0.0559},{"period":"1month","weight":-0.2748},{"period":"3month","weight":-0.4509},{"period":"6month","weight":-0.6584},{"period":"1year","weight":-0.9076},{"period":"ytd","weight":-0.7799}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers Symphony platform, a technology platform comprising Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. It also provides ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 test for the monitoring of disease progression in critical care settings. Further, it develops cardiac biomarkers, such as hsTNT and NT pro-BNP, as well as other tests using the Symphony platform. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.09176},{"month":2,"riseRate":0.4,"avgChangeRate":-0.020494},{"month":3,"riseRate":0.4,"avgChangeRate":-0.104322},{"month":4,"riseRate":0.2,"avgChangeRate":-0.223757},{"month":5,"riseRate":0.4,"avgChangeRate":-0.039698},{"month":6,"riseRate":0.4,"avgChangeRate":-0.217872},{"month":7,"riseRate":0.4,"avgChangeRate":-0.088216},{"month":8,"riseRate":0.2,"avgChangeRate":-0.172986},{"month":9,"riseRate":0.2,"avgChangeRate":-0.144886},{"month":10,"riseRate":0.4,"avgChangeRate":-0.102022},{"month":11,"riseRate":0.2,"avgChangeRate":-0.144233},{"month":12,"riseRate":0.2,"avgChangeRate":-0.253394}],"exchange":"NASDAQ","name":"Bluejay Diagnostics Inc","nameEN":"Bluejay Diagnostics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Bluejay Diagnostics Inc(BJDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Bluejay Diagnostics Inc,BJDX,Bluejay Diagnostics Inc股票,Bluejay Diagnostics Inc股票老虎,Bluejay Diagnostics Inc股票老虎国际,Bluejay Diagnostics Inc行情,Bluejay Diagnostics Inc股票行情,Bluejay Diagnostics Inc股价,Bluejay Diagnostics Inc股市,Bluejay Diagnostics Inc股票价格,Bluejay Diagnostics Inc股票交易,Bluejay Diagnostics Inc股票购买,Bluejay Diagnostics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bluejay Diagnostics Inc(BJDX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Bluejay Diagnostics Inc(BJDX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction